Extracorporeal Shock-Wave Lithotripsy and Endoscopy for the Treatment of Pain in Chronic Pancreatitis: A Sham-Controlled, Randomized Trial.

Some patients with chronic pancreatitis experience pancreatic duct obstruction caused by stones, which may contribute to chronic abdominal pain. Although relieving this obstruction through a procedure known as extracorporeal shock-wave lithotripsy could potentially alleviate the pain, there is no high-quality evidence demonstrating the benefit of such intervention. The objective of this randomized, sham-controlled trial was to assess the efficacy and safety of pancreatic duct decompression through lithotripsy and endoscopic retrograde pancreatography. Visual Abstract. Extracorporeal Shock-Wave Lithotripsy and Endoscopy for the Treatment of Pain in Chronic Pancreatitis: Some patients with chronic pancreatitis experience pancreatic duct obstruction caused by stones, which may contribute to chronic abdominal pain. Although relieving this obstruction through a procedure known as extracorporeal shock-wave lithotripsy could potentially alleviate the pain, there is no high-quality evidence demonstrating the benefit of such intervention. The objective of this randomized, sham-controlled trial was to assess the efficacy and safety of pancreatic duct decompression through lithotripsy and endoscopic retrograde pancreatography. Background: No randomized controlled trials have substantiated endoscopic decompression of the pancreatic duct in patients with painful chronic pancreatitis. Objective: To investigate the pain-relieving effect of pancreatic duct decompression in patients with chronic pancreatitis and intraductal stones. Design: 24-week, parallel-group, randomized controlled trial (ClinicalTrials.gov: NCT03966781) Setting: Asian Institute of Gastroenterology in India from February 2021 to July 2022. Participants: 106 patients with chronic pancreatitis. Intervention: Combined extracorporeal shock-wave lithotripsy (ESWL) and endoscopic retrograde pancreatography (ERP) compared with sham procedures. Measurements: The primary end point was pain relief on a 0- to 10-point visual analog scale (VAS) at 12 weeks. Secondary outcomes were assessed after 12 and 24 weeks and included 30% pain relief, opioid use, pain-free days, questionaries, and complications to interventions. Results: 52 patients in the ESWL/ERP group and 54 in the sham group were included. At 12 weeks, the ESWL/ERP group showed better pain relief compared with the sham group (mean difference in change, −0.7 [95% CI, −1.3 to 0] on the VAS; P  = 0.039). The difference between groups was not sustained at the 24-week follow-up, and no differences were seen for 30% pain relief at 12- or 24-week follow-up. The number of pain-free days was increased (median difference, 16.2 days [CI, 3.9 to 28.5 days]), and the number of days using opioids was reduced (median difference, −5.4 days [CI, −9.9 to −0.9 days]) in the ESWL/ERP group compared with the sham group at 12-week follow-up. Safety outcomes were similar between groups. Limitation: Single-center study and limited duration of follow-up. Conclusion: In patients with chronic pancreatitis and intraductal stones, ESWL with ERP provided modest short-term pain relief. Primary Funding Source: Asian Institute of Gastroenterology and Aalborg University Hospital. [ABSTRACT FROM AUTHOR]